416.68
USD
0.61
(0.15%)
Market Closed
Last updated: · Delayed 15 min
BeiGene debt to equity ratioWhat is the debt to equity ratio? Debt to equity is a company's total debt divided by its shareholders' equity: how much it has borrowed for each dollar its owners have in the business.
BeiGene's debt to equity ratio is 0.20: total debt of 1.15B USD against shareholders' equity of 5.82B USD.
- Today
- 0.20
- Average, 5 years
- 0.23
- Low, 5 years
- 0.11
- High, 5 years
- 0.46
Debt to equity = total debt ÷ shareholders' equity = 1.15B ÷ 5.82B = 0.20
Debt to equity
Total debt
Shareholders' equity
Total debt over shareholders' equity at each quarter end.
Debt to equity by year and by quarter
| Fiscal year | Period ending | Debt to equity | Total debt | Shareholders' equity |
|---|---|---|---|---|
| Today | 0.20 | 1.15B | 5.82B | |
| FY2025 | 31 Dec 2025 | 0.46 | 2.00B | 4.36B |
| FY2024 | 31 Dec 2024 | 0.32 | 1.08B | 3.33B |
| FY2023 | 31 Dec 2023 | 0.26 | 930.19M | 3.54B |
| FY2022 | 31 Dec 2022 | 0.14 | 596.68M | 4.38B |
| FY2021 | 31 Dec 2021 | 0.11 | 694.64M | 6.13B |
| FY2020 | 31 Dec 2020 | 0.15 | 561.96M | 3.87B |
| FY2019 | 31 Dec 2019 | 0.29 | 277.34M | 962.21M |
| FY2018 | 31 Dec 2018 | 0.11 | 198.40M | 1.75B |
| FY2017 | 31 Dec 2017 | 0.24 | 164.72M | 684.23M |
| FY2016 | 31 Dec 2016 | 0.05 | 17.28M | 352.91M |
| FY2015 | 31 Dec 2015 | — | 20.79M | -101.77M |
| FY2014 | 31 Dec 2014 | 0.54 | 13.84M | 25.77M |
| FY2013 | 31 Dec 2013 | — | 27.36M | -38.73M |
| Quarter | Period ending | Debt to equity | Total debt | Shareholders' equity |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 0.20 | 1.15B | 5.82B |
| Q2 FY2026 | 30 Jun 2026 | 0.22 | 1.14B | 5.17B |
| Q1 FY2026 | 31 Mar 2026 | 0.24 | 1.15B | 4.76B |
| Q4 FY2025 | 31 Dec 2025 | 0.46 | 2.00B | 4.36B |
| Q3 FY2025 | 30 Sept 2025 | 0.25 | 1.02B | 4.13B |
| Q2 FY2025 | 30 Jun 2025 | 0.27 | 1.03B | 3.77B |
| Q1 FY2025 | 31 Mar 2025 | 0.28 | 996.83M | 3.50B |
| Q4 FY2024 | 31 Dec 2024 | 0.32 | 1.08B | 3.33B |
| Q3 FY2024 | 30 Sept 2024 | 0.32 | 1.10B | 3.44B |
| Q2 FY2024 | 30 Jun 2024 | 0.32 | 1.09B | 3.37B |
| Q1 FY2024 | 31 Mar 2024 | 0.32 | 1.06B | 3.36B |
| Q4 FY2023 | 31 Dec 2023 | 0.26 | 930.19M | 3.54B |
| Q3 FY2023 | 30 Sept 2023 | 0.15 | 579.77M | 3.76B |
| Q2 FY2023 | 30 Jun 2023 | 0.18 | 677.81M | 3.80B |
| Q1 FY2023 | 31 Mar 2023 | 0.13 | 545.19M | 4.16B |
| Q4 FY2022 | 31 Dec 2022 | 0.14 | 596.68M | 4.38B |
| Q3 FY2022 | 30 Sept 2022 | 0.15 | 710.58M | 4.66B |
| Q2 FY2022 | 30 Jun 2022 | 0.12 | 632.65M | 5.30B |
| Q1 FY2022 | 31 Mar 2022 | 0.11 | 671.88M | 5.89B |
| Q4 FY2021 | 31 Dec 2021 | 0.11 | 694.64M | 6.13B |
| Q3 FY2021 | 30 Sept 2021 | 0.21 | 699.54M | 3.36B |
| Q2 FY2021 | 30 Jun 2021 | 0.19 | 680.38M | 3.61B |
| Q1 FY2021 | 31 Mar 2021 | 0.16 | 638.62M | 4.00B |
| Q4 FY2020 | 31 Dec 2020 | 0.15 | 561.96M | 3.87B |
| Q3 FY2020 | 30 Sept 2020 | 0.06 | 243.73M | 4.29B |
| Q2 FY2020 | 30 Jun 2020 | 0.14 | 361.77M | 2.54B |
| Q1 FY2020 | 31 Mar 2020 | 0.11 | 298.05M | 2.81B |
| Q4 FY2019 | 31 Dec 2019 | 0.29 | 277.34M | 962.21M |
| Q3 FY2019 | 30 Sept 2019 | 0.22 | 285.21M | 1.28B |
| Q2 FY2019 | 30 Jun 2019 | 0.18 | 275.38M | 1.57B |
| Q1 FY2019 | 31 Mar 2019 | 0.17 | 270.59M | 1.61B |
| Q4 FY2018 | 31 Dec 2018 | 0.11 | 198.40M | 1.75B |
| Q3 FY2018 | 30 Sept 2018 | 0.10 | 195.97M | 1.98B |
| Q2 FY2018 | 30 Jun 2018 | 0.17 | 209.75M | 1.21B |
| Q1 FY2018 | 31 Mar 2018 | 0.13 | 173.68M | 1.34B |
| Q4 FY2017 | 31 Dec 2017 | 0.24 | 164.72M | 684.23M |
| Q3 FY2017 | 30 Sept 2017 | 0.21 | 158.35M | 750.14M |
| Q2 FY2017 | 30 Jun 2017 | 0.60 | 152.73M | 255.75M |
| Q1 FY2017 | 31 Mar 2017 | 0.06 | 19.90M | 308.42M |
| Q4 FY2016 | 31 Dec 2016 | 0.05 | 17.28M | 352.91M |
| Q3 FY2016 | 30 Sept 2016 | 0.10 | 18.03M | 187.83M |
| Q2 FY2016 | 30 Jun 2016 | 0.05 | 10.55M | 220.05M |
| Q1 FY2016 | 31 Mar 2016 | 0.03 | 6.21M | 243.10M |
| Q4 FY2015 | 31 Dec 2015 | — | 20.79M | -101.77M |
| Q3 FY2015 | 30 Sept 2015 | 0.21 | 20.63M | 100.08M |
| Q2 FY2015 | 30 Jun 2015 | 0.13 | 14.05M | 109.91M |
| Q1 FY2015 | 31 Mar 2015 | 0.00 | 0.00 | 25.77M |
| Q4 FY2014 | 31 Dec 2014 | 0.54 | 13.84M | 25.77M |
| Q3 FY2014 | 30 Sept 2014 | — | — | — |
| Q2 FY2014 | 30 Jun 2014 | — | — | — |
| Q1 FY2014 | 31 Mar 2014 | — | — | — |
Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.
See also:Market cap,P/S ratio,ROE (return on equity),Current ratio,All ratios
Common questions about BeiGene's debt to equity
Source: Financial Modeling Prep
